Imaging bone metastases in breast cancer: techniques and recommendations for diagnosis.

[1]  Jingfei Ma,et al.  Fast dixon‐based multisequence and multiplanar MRI for whole‐body detection of cancer metastases , 2009, Journal of magnetic resonance imaging : JMRI.

[2]  Seong-Jang Kim,et al.  Clinical implication of F-18 FDG PET/CT for differentiated thyroid cancer in patients with negative diagnostic iodine-123 scan and elevated thyroglobulin. , 2009, European journal of radiology.

[3]  C. Greco,et al.  Whole-body magnetic resonance imaging for detecting bone metastases: comparison with bone scintigraphy , 2008, La radiologia medica.

[4]  D. Fuster,et al.  Preoperative staging of large primary breast cancer with [18F]fluorodeoxyglucose positron emission tomography/computed tomography compared with conventional imaging procedures. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  C. Claussen,et al.  Nachweis ossärer metastasen des prostatakarzinoms - Vergleich der leistungsfähigkeit der ganzkörper-mrt und der skelettszintigrafie , 2008 .

[6]  S. Matsumoto,et al.  Non-small cell lung cancer: whole-body MR examination for M-stage assessment--utility for whole-body diffusion-weighted imaging compared with integrated FDG PET/CT. , 2008, Radiology.

[7]  J. Choi,et al.  Non-small cell lung cancer staging: efficacy comparison of integrated PET/CT versus 3.0-T whole-body MR imaging. , 2008, Radiology.

[8]  D. Groheux,et al.  Effect of (18)F-FDG PET/CT imaging in patients with clinical Stage II and III breast cancer. , 2008, International journal of radiation oncology, biology, physics.

[9]  E. Rummeny,et al.  [Whole-body MRI in children with langerhans cell histiocytosis for the evaluation of the skeletal system]. , 2008, RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin.

[10]  A. Scarsbrook,et al.  Impact of the introduction of integrated PET-CT into the preoperative staging pathway of patients with potentially operable oesophageal carcinoma. , 2008, Clinical radiology.

[11]  W. Huda,et al.  Effective doses in radiology and diagnostic nuclear medicine: a catalog. , 2008, Radiology.

[12]  M. Viallon,et al.  Whole-Body MRI for Metastases Screening: A Preliminary Study Using 3D VIBE Sequences With Automatic Subtraction Between Noncontrast and Contrast Enhanced Images , 2008, American journal of clinical oncology.

[13]  M. Mancini,et al.  Role of whole-body [18F] fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) and conventional techniques in the staging of patients with Hodgkin and aggressive non Hodgkin lymphoma , 2008, La radiologia medica.

[14]  T. Watts,et al.  Identification of Distant Metastases With Positron–Emission Tomography‐Computed Tomography in Patients With Previously Untreated Head and Neck Cancer , 2008, The Laryngoscope.

[15]  S. Schoenberg,et al.  Whole-body MRI versus whole-body MDCT for staging of multiple myeloma. , 2008, AJR. American journal of roentgenology.

[16]  Roberto Cardarelli,et al.  Meta-analysis: Comparison of F-18 Fluorodeoxyglucose-Positron Emission Tomography and Bone Scintigraphy in the Detection of Bone Metastases in Patients With Breast Cancer , 2008, Clinical nuclear medicine.

[17]  S. Schoenberg,et al.  Comprehensive imaging of tumor recurrence in breast cancer patients using whole-body MRI at 1.5 and 3 T compared to FDG-PET-CT. , 2008, European journal of radiology.

[18]  E. Squillaci,et al.  Staging of colon cancer: whole-body MRI vs. whole-body PET-CT—initial clinical experience , 2008, Abdominal Imaging.

[19]  I. V. D. van der Ploeg,et al.  The Additional Value of SPECT/CT in Lymphatic Mapping in Breast Cancer and Melanoma , 2007, Journal of Nuclear Medicine.

[20]  Devraj Basu,et al.  Detection of occult bone metastases from head and neck squamous cell carcinoma: impact of positron emission tomography computed tomography with fluorodeoxyglucose F 18. , 2007, Archives of otolaryngology--head & neck surgery.

[21]  N. Hall,et al.  Impact of [18F]‐2‐Fluorodeoxyglucose–Positron Emission Tomography/Computed Tomography on Previously Untreated Head and Neck Cancer Patients , 2007, The Laryngoscope.

[22]  S. Zincirkeser,et al.  Detection of Metastases in Patients with Cutaneous Melanoma Using FDG-PET/CT , 2007, The Journal of international medical research.

[23]  Takeo Ishigaki,et al.  Comparison of 18F-FDG PET and Bone Scintigraphy in Detection of Bone Metastases of Thyroid Cancer , 2007, Journal of Nuclear Medicine.

[24]  G. Antoch,et al.  Whole-body PET/CT-colonography: a possible new concept for colorectal cancer staging , 2007, Abdominal Imaging.

[25]  L. Steinbach,et al.  MRI findings of prolonged post-traumatic sternal pain , 2007, Skeletal Radiology.

[26]  Ur Metser,et al.  Improved sentinel node identification by SPECT/CT in overweight patients with breast cancer. , 2007, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[27]  C. Claussen,et al.  Comparison of 11C-choline-PET/CT and whole body-MRI for staging of prostate cancer , 2006, Nuklearmedizin.

[28]  Katsuyuki Nakanishi,et al.  Whole-body MRI for detecting metastatic bone tumor: diagnostic value of diffusion-weighted images. , 2007, Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine.

[29]  R. Munden,et al.  Detection of interval distant metastases , 2007, Cancer.

[30]  S. Schoenberg,et al.  Screening for bone metastases: whole-body MRI using a 32-channel system versus dual-modality PET-CT , 2007, European Radiology.

[31]  W. De Wever,et al.  Additional value of integrated PET-CT in the detection and characterization of lung metastases: correlation with CT alone and PET alone , 2007, European Radiology.

[32]  D. Yang,et al.  Whole-body MRI of Langerhans cell histiocytosis: comparison with radiography and bone scintigraphy , 2006, Pediatric Radiology.

[33]  Torsten Kuwert,et al.  SPECT-guided CT for evaluating foci of increased bone metabolism classified as indeterminate on SPECT in cancer patients. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[34]  J. Bucerius,et al.  Diagnostic Performance of Whole Body Dual Modality 18F-FDG PET/CT Imaging for N- and M-Staging of Malignant Melanoma: Experience With 250 Consecutive Patients , 2006 .

[35]  T. Beyer,et al.  Whole body positron emission tomography/computed tomography (PET/CT) tumour staging with integrated PET/CT colonography: technical feasibility and first experiences in patients with colorectal cancer , 2005, Gut.

[36]  A. Iagaru,et al.  2-Deoxy-2-[F-18]fluoro-d-glucose Positron Emission Tomography/Computed Tomography in the Management of Melanoma , 2006, Molecular Imaging and Biology.

[37]  M. Liebergall,et al.  Early diagnosis of occult hip fractures MRI versus CT scan. , 2005, Injury.

[38]  M. Endo,et al.  Comparison of FDG PET and SPECT for detection of bone metastases in breast cancer. , 2005, AJR. American journal of roentgenology.

[39]  SPECT/Spiral-CT hybrid imaging in unclear foci of increased bone metabolism: a case report. , 2005, Rontgenpraxis; Zeitschrift fur radiologische Technik.

[40]  J. Debatin,et al.  Whole-body MR imaging: evaluation of patients for metastases. , 2004, Radiology.

[41]  Naoto T Ueno,et al.  Bone imaging in metastatic breast cancer. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[42]  Thomas J. Smith,et al.  American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[43]  E. Imhoff,et al.  Comparison of whole-body MRI with automatic moving table technique and bone scintigraphy for screening for bone metastases in patients with breast cancer , 2004, European Radiology.

[44]  J. Debatin,et al.  Whole-body dual-modality PET/CT and whole-body MRI for tumor staging in oncology. , 2003, JAMA.

[45]  G. V. von Schulthess,et al.  Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. , 2003, The New England journal of medicine.

[46]  T. McCauley,et al.  Discrimination of metastatic from acute osteoporotic compression spinal fractures with MR imaging. , 2003, Radiographics : a review publication of the Radiological Society of North America, Inc.

[47]  S. Yang,et al.  Comparing whole body 18F-2-deoxyglucose positron emission tomography and technetium-99m methylene diphosphonate bone scan to detect bone metastases in patients with breast cancer , 2002, Journal of Cancer Research and Clinical Oncology.

[48]  S. Yasuda,et al.  Whole body PET for the evaluation of bony metastases in patients with breast cancer: comparison with 99Tcm-MDP bone scintigraphy , 2001, Nuclear medicine communications.

[49]  C. Kao,et al.  Comparison and discrepancy of 18F-2-deoxyglucose positron emission tomography and Tc-99m MDP bone scan to detect bone metastases. , 2000, Anticancer research.

[50]  M. Fukunaga,et al.  [Comparison of whole-body MR imaging and bone scintigraphy in the detection of bone metastases from breast cancer]. , 2000, Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica.

[51]  R. Walker,et al.  Turbo STIR magnetic resonance imaging as a whole‐body screening tool for metastases in patients with breast carcinoma: Preliminary clinical experience , 2000, Journal of magnetic resonance imaging : JMRI.

[52]  N. Budihna,et al.  The benefit of SPECT when added to planar scintigraphy in patients with bone metastases in the spine. , 1999, Clinical nuclear medicine.

[53]  L. Horvath,et al.  Total-body echo-planar MR imaging in the staging of breast cancer: comparison with conventional methods--early experience. , 1999, Radiology.

[54]  M. Reiser,et al.  Whole-body bone marrow MRI in patients with metastatic disease to the skeletal system. , 1999, Journal of computer assisted tomography.

[55]  R. Rubens,et al.  Detection of bone metastases in breast cancer by 18FDG PET: differing metabolic activity in osteoblastic and osteolytic lesions. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[56]  T. Au-yong,et al.  Comparison of bone single-photon emission tomography and planar imaging in the detection of vertebral metastases in patients with back pain , 1998, European Journal of Nuclear Medicine.

[57]  E. Melhem,et al.  A comparison of whole-body turboSTIR MR imaging and planar 99mTc-methylene diphosphonate scintigraphy in the examination of patients with suspected skeletal metastases. , 1997, AJR. American journal of roentgenology.

[58]  R. Costa.  Bone and Joint Imaging. 2nd ed , 1997 .

[59]  C. Cuénod,et al.  Acute vertebral collapse due to osteoporosis or malignancy: appearance on unenhanced and gadolinium-enhanced MR images. , 1996, Radiology.

[60]  W. Hayes,et al.  Predicting pathologic fracture risk in the management of metastatic bone defects. , 1995, Clinical orthopaedics and related research.

[61]  D. Resnick.  Bone and Joint Imaging , 1989 .

[62]  R. Tadmor,et al.  Early MR Demonstration of Spinal Metastases in Patients with Normal Radiographs and CT and Radionuclide Bone Scans , 1989, Journal of computer assisted tomography.

[63]  W T Yuh,et al.  Vertebral compression fractures: distinction between benign and malignant causes with MR imaging. , 1989, Radiology.

[64]  J. Tehranzadeh,et al.  Comparison of CT and MR Imaging in Musculoskeletal Neoplasms , 1989, Journal of computer assisted tomography.

[65]  R. Rubens,et al.  The clinical course of bone metastases from breast cancer. , 1987, British Journal of Cancer.

[66]  A. Aisen,et al.  MRI and CT evaluation of primary bone and soft-tissue tumors. , 1986, AJR. American journal of roentgenology.

[67]  F. Sim,et al.  Bone tumors: magnetic resonance imaging versus computed tomography. , 1985, Radiology.